Aclaris Therapeutics to Acquire Worldwide Rights to RHOFADEĀ® from Allergan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
Go back to Aclaris Therapeutics to Acquire Worldwide Rights to RHOFADEĀ® from Allergan
October 15, 2018 4:04 PM EDT
Aclaris Therapeutics (NASDAQ: ACRS) to Resume Trading at 4:30 pm ET
...
More